Skip to content

Prostatype Genomics AB

Active in EUDAMED

Swedenfrom SRN EUDAMED SRN SE-MF-000013349

Devices
3
Registrations
EUDAMED

At a glance

Counted by deviCERTS from registry records

Market reach

European Union
EUDAMED actor

Catalogue3

Newest first, rows 1-3 of 3

Company details

EUDAMED SRN
SE-MF-000013349
EU VAT number
SE 556726028501
EUDAMED status
Active
EUDAMED registered name
Prostatype Genomics AB
Registered address
20, Augustendalsvägen, 13152, Nacka Strand, Sweden
Phone
+46 8 20 87 00‬‬
PRRC contact
Nina Helenius(public in EUDAMED)

From the company website

Read 18 Oct 2026

Prostatype Genomics Prostate cancer is one of the most common forms of cancer and approximately 1.3 million men are diagnosed annually. Prostatype Genomics AB specializes in the development, manufacturing, and marketing of the prognostic genetic test Prostatype®. Prostatype® is a genetic test that provides a comprehensive assessment of the aggressiveness of prostate cancer. The Prostatype \[…\]

From the manufacturer's own website. Source

Frequently asked questions

How many devices does Prostatype Genomics AB have in the registry?

The registry currently lists 3 devices for Prostatype Genomics AB. Devices recorded under merged duplicate company entries are counted once.

Which registries list Prostatype Genomics AB's devices?

Among its 3 most recently registered devices, Prostatype Genomics AB has devices listed in EUDAMED (3 devices).

What risk classes do Prostatype Genomics AB's devices fall under?

Among its 3 most recently registered devices, the classes recorded for Prostatype Genomics AB's devices are IVDR Class C. Each device page shows its own class and authorisation.

What are the newest devices from Prostatype Genomics AB in the registry?

The most recently registered devices listed for Prostatype Genomics AB include Prostatype® RT qPCR Kit and P-score Web Service (PWS).

Generated automatically from registry data and not verified by a human reviewer.